Skip to main content
Advertisement
  • Other Publications
    • EMBO Press
    • The EMBO Journal (Home)
    • EMBO reports
    • EMBO Molecular Medicine
    • Molecular Systems Biology
    • Life Science Alliance
Login

   

Search

Advanced Search

Journal

  • Home
  • Latest Online
  • Current Issue
  • Archive
  • Subject Collections
  • Review Series & Focuses

Authors & Referees

  • Submit
  • Author Guidelines
  • Aims & Scope
  • Editors & Board
  • Transparent Process
  • Bibliometrics
  • Referee Guidelines
  • Open Access Charges

Info

  • E-Mail Editorial Office
  • Alerts
  • RSS Feeds
  • Subscriptions & Access
  • Reprints & Permissions
  • Advertise & Sponsor
  • Media Partners
  • News & Press
  • Recommend to Librarian
  • Customer Service
  • About
  • Archive
  • Author Guidelines
  • Submit
  • E-alert

Advanced Search

  • Postsynaptic localization and regulation of AMPA receptors and Cav1.2 by β2 adrenergic receptor/PKA and Ca2+/CaMKII signaling

    REVIEW

    T Patriarchi, OR Buonarati, JW Hell

    A comprehensive review of postsynaptic signaling pathways illustrates the complex structural and functional framework required to accurately regulate synaptic strength

  • SHLD2/FAM35A co‐operates with REV7 to coordinate DNA double‐strand break repair pathway choice

    S Findlay, J Heath, A Orthwein and colleagues

    Proteomic interaction and CRISPR/Cas9 doxorubicin sensitivity screens identify the sought‐after effectors through which the 53BP1/RIF1/REV7 axis antagonizes DNA break resection and promotes non‐homologous end‐joining repair.

  • Parkinson's disease: convergence on synaptic homeostasis

    REVIEW

    SF Soukup, R Vanhauwaert, P Verstreken

    A comprehensive overview of the interplay between synaptic dysfunction and neurodegeneration in Parkinson's disease details the roles of disease‐associated regulators of protein homeostasis, endocytosis and autophagy in synaptic homeostasis.

  • Latest Online
  • Current Issue
  • Most Read
Loading
  • Open Access
    Article
    Esrrb extinction triggers dismantling of naïve pluripotency and marks commitment to differentiation
    Esrrb extinction triggers dismantling of naïve pluripotency and marks commitment to differentiation
    1. Nicola Festuccia (n.festuccia{at}lms.mrc.ac.uk)*,1,3,
    2. Florian Halbritter1,4,6,
    3. Andrea Corsinotti1,2,
    4. Alessia Gagliardi1,5,
    5. Douglas Colby1,
    6. Simon R Tomlinson1 and
    7. Ian Chambers (ichambers{at}ed.ac.uk)*,1
    1. 1MRC Centre for Regenerative Medicine, Institute for Stem Cell Research, School of Biological Sciences, University of Edinburgh, Edinburgh, UK
    2. 2Department of Anatomy and Embryology, Faculty of Medicine, University of Tsukuba, Ibaraki, Japan
    3. 3Present Address: MRC London Institute of Medical Sciences, Institute of Clinical Sciences, Faculty of Medicine Imperial College London, London, UK
    4. 4Present Address: CeMM Research Center for Molecular Medicine of the Austrian Academy of Sciences, Vienna, Austria
    5. 5Present Address: Children's Cancer Research Institute, St. Anna Kinderkrebsforschung, Vienna, Austria
    6. 6Present Address: Canada's Michael Smith Genome Sciences Centre, BC Cancer Agency, Vancouver, BC, Canada
    1. ↵* Corresponding author. Tel: +44 20 8383 8228; E‐mail: n.festuccia{at}lms.mrc.ac.uk
      Corresponding author. Tel: +44 131 651 9562; Fax: +44 131 651 9501; E‐mail: ichambers{at}ed.ac.uk

    Differential Esrrb transcription factor expression instructs differentiation kinetics of mouse embryonic stem cells.

    Synopsis

    Embryonic stem cell (ESC) populations cultured in LIF‐containing serum heterogeneously express NANOG and ESRRB transcription factors (TFs), and contain both self‐renewing cells as well as cells initiating differentiation. Using fluorescent knock‐in reporters, mouse ESCs are shown to be heterogeneous in self‐renewal, gene expression, and regulatory element activities during exit from naïve pluripotency.

    • Downregulation of NANOG is required for loss of ESRRB in LIF/FCS culture of ESCs.

    • Loss of ESRRB marks commitment to differentiation.

    • Co‐binding of OCT4 at regulatory sites in ESRRB‐high ESCs is differentially dependent on NANOG and other naïve pluripotency TFs.

    • Genes proximal to regulatory elements losing OCT4 binding are preferentially expressed in naïve cells.

    • commitment
    • embryonic stem cells
    • fluorescent reporters
    • self‐renewal
    • transcription factors

    The EMBO Journal (2018): e95476

    • Received December 14, 2016.
    • Revision received August 24, 2018.
    • Accepted August 27, 2018.
    • © 2018 The Authors. Published under the terms of the CC BY 4.0 license

    This is an open access article under the terms of the Creative Commons Attribution 4.0 License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.

    Nicola Festuccia, Florian Halbritter, Andrea Corsinotti, Alessia Gagliardi, Douglas Colby, Simon R Tomlinson, Ian Chambers
    Published online 01.10.2018
  • You have accessRestricted access
    Article
    Nonsense‐mediated mRNA decay involves two distinct Upf1‐bound complexes
    Nonsense‐mediated mRNA decay involves two distinct Upf1‐bound complexes
    1. Marine Dehecq1,2,
    2. Laurence Decourty1,
    3. Abdelkader Namane1,
    4. Caroline Proux3,
    5. Joanne Kanaan4,
    6. Hervé Le Hir4,
    7. Alain Jacquier1 and
    8. Cosmin Saveanu (cosmin.saveanu{at}pasteur.fr)*,1
    1. 1Génétique des Interactions Macromoléculaires, Genomes and Genetics Department, Institut Pasteur, Paris, France
    2. 2Université Pierre et Marie Curie, Paris, France
    3. 3Transcriptome and Epigenome, CITECH, Institut Pasteur, Paris, France
    4. 4Expression des ARN Messagers Eucaryotes, Biology Department, CNRS UMR8197, Inserm U1024, Institut de Biologie de l'Ecole Normale Supérieure, Paris, France
    1. ↵*Corresponding author. Tel: +33 1 44 38 92 80; E‐mail: cosmin.saveanu{at}pasteur.fr

    Distinct mechanisms for Nonsense‐Mediated mRNA Decay (NMD) have been proposed in different organisms. Proteomics‐based characterization of NMD complexes in yeast reveals the existence of two mutually exclusive complexes that may provide a universal model for NMD.

    Synopsis

    A number of partly contradictory mechanisms have been proposed for Nonsense‐Mediated RNA Decay (NMD). Proteomics‐based characterization of NMD complexes in Saccharomyces cerevisiae identifies two mutually exclusive complexes that may provide a universal mechanism for NMD.

    • Enrichment computation based on label‐free quantitative mass‐spectrometry and total protein abundance discriminates between true interacting proteins and contaminants.

    • NMD factors bind to the core NMD protein Upf1 as two distinct complexes: Upf1‐23 complex (Upf1/2/3) and Upf1‐decapping (Upf1/decapping factors/Ebs1/Nmd4).

    • The Upf1‐decapping complex binds specifically to NMD target RNAs and is associated with monosomes and polysomes.

    • Smg‐5/7 (Ebs1) and Smg‐6 (Nmd4) homologues are required for yeast NMD, suggesting that NMD mechanisms are more conserved than previously thought.

    • affinity purification
    • NMD
    • quantitative mass spectrometry
    • RNA decay
    • Saccharomyces cerevisiae

    The EMBO Journal (2018) e99278

    • Received February 20, 2018.
    • Revision received August 10, 2018.
    • Accepted August 22, 2018.
    • © 2018 The Authors
    Marine Dehecq, Laurence Decourty, Abdelkader Namane, Caroline Proux, Joanne Kanaan, Hervé Le Hir, Alain Jacquier, Cosmin Saveanu
    Published online 01.10.2018
    • Protein Biosynthesis & Quality Control
    • RNA Biology
  • You have accessRestricted access
    News & Views
    Alpha‐ketoglutarate: a “magic” metabolite in early germ cell development
    Alpha‐ketoglutarate: a “magic” metabolite in early germ cell development
    1. Vivian Lu1 and
    2. Michael A Teitell (mteitell{at}mednet.ucla.edu)2,3,4,5,6,7
    1. 1Department of Molecular and Medical Pharmacology, UCLA, Los Angeles, CA, USA
    2. 2Department of Pathology and Laboratory Medicine, UCLA, Los Angeles, CA, USA
    3. 3California NanoSystems Institute, UCLA, Los Angeles, CA, USA
    4. 4Department of Bioengineering, UCLA, Los Angeles, CA, USA
    5. 5Molecular Biology Institute, UCLA, Los Angeles, CA, USA
    6. 6Eli and Edythe Broad Center of Regenerative Medicine, UCLA, Los Angeles, CA, USA
    7. 7Jonsson Comprehensive Cancer Center, UCLA, Los Angeles, CA, USA

    A causal relationship between cell metabolism and the fate of pluripotent stem cells through epigenome regulation is emerging. A recent study shows that the tricarboxylic acid cycle intermediate alpha‐ketoglutarate (αKG) can both sustain naïve mouse embryonic stem cell pluripotency and promote primordial germ cell differentiation. This observation together with other studies provides intriguing possibilities for stabilizing ephemeral embryonic cell states and enhancing desired fate transitions through specific metabolite manipulations.

    See also: J Tischler et al

    Recent implications of a Krebs cycle intermediate in stem cell pluripotency and differentiation suggest possibilities for stabilizing ephemeral embryonic cell states and enhancing desired fate transitions through specific metabolite manipulations.

    The EMBO Journal (2018) e100615

    • © 2018 The Authors
    Vivian Lu, Michael A Teitell
    Published online 01.10.2018
    • Development & Differentiation
    • Metabolism
    • Stem Cells
  • You have accessRestricted access
    News & Views
    Epigenetically jump starting de novo shoot regeneration
    Epigenetically jump starting <em>de novo</em> shoot regeneration
    1. Ning Zhang1 and
    2. Thomas Laux (laux{at}biologie.uni-freiburg.de)1,2
    1. 1BIOSS Centre for Biological Signaling Studies, Faculty of Biology, Albert‐Ludwigs‐Universität Freiburg, Freiburg, Germany
    2. 2Sino‐German Joint Research Center on Agricultural Biology, Shandong Agricultural University, Tai'an, Shandong, China

    The ability to regenerate lost organs or tissues is a central requirement for animals and plants in order to cope with injury. Regeneration of a whole body is rare in animals but is more commonly found in plants where in vitro regeneration has become a widely used tool in plant research. In a new study, Kim et al find that epigenetic changes via the histone acetyltransferase HAG1 establish the competency for shoot regeneration from callus by promoting the expression of root stem cell factors.

    See also: JY Kim et al

    The histone acetyltransferase HAG1 drives plant regeneration from callus by promoting the expression of root stem cell factors.

    The EMBO Journal (2018) e100596

    • © 2018 The Authors
    Ning Zhang, Thomas Laux
    Published online 01.10.2018
    • Chromatin, Epigenetics, Genomics & Functional Genomics
    • Development & Differentiation
    • Plant Biology
  • Open Access
    Article
    Chemical genetic identification of CDKL5 substrates reveals its role in neuronal microtubule dynamics
    Chemical genetic identification of CDKL5 substrates reveals its role in neuronal microtubule dynamics
    1. Lucas L Baltussen1,†,
    2. Priscilla D Negraes2,†,
    3. Margaux Silvestre1,
    4. Suzanne Claxton1,
    5. Max Moeskops1,
    6. Evangelos Christodoulou3,
    7. Helen R Flynn4,
    8. Ambrosius P Snijders4,
    9. Alysson R Muotri (muotri{at}ucsd.edu)*,2,5 and
    10. Sila K Ultanir (sila.ultanir{at}crick.ac.uk)*,1
    1. 1Kinases and Brain Development Laboratory, The Francis Crick Institute, London, UK
    2. 2Department of Pediatrics, School of Medicine, University of California San Diego, La Jolla, CA, USA
    3. 3Structural Biology Science Technology Platform, The Francis Crick Institute, London, UK
    4. 4Proteomics Science Technology Platform, The Francis Crick Institute, London, UK
    5. 5Department of Pediatrics/Cellular & Molecular Medicine, Center for Academic Research and Training in Anthropogeny (CARTA), Kavli Institute for Brain and Mind, School of Medicine, Rady Children's Hospital San Diego, University of California San Diego, La Jolla, CA, USA
    1. ↵* Corresponding author. Tel: +1 858 534 9320; E‐mail: muotri{at}ucsd.edu
      Corresponding author. Tel: +44 20 3796 1613; E‐mail: sila.ultanir{at}crick.ac.uk
    1. ↵† These authors contributed equally to this work

    The finding of decreased microtubule affinity of CDKL5‐phosphorylated MAP1S provides new insights into a possible pathogenic pathway of neurodevelopmental CDKL5 deficiency disorder.

    Synopsis

    Chemical genetic identification of physiological CDKL5 substrates EB2 and MAP1S reveals its role as a regulator of neuronal microtubule dynamics. MAP1S phosphorylation decreases microtubule affinity, suggesting a possible pathogenic pathway of CDKL5 deficiency disorder (CDD).

    • CDKL5 directly phosphorylates the RPXS* motif of microtubule‐associated proteins EB2, MAP1S and ARHGEF2.

    • EB2 and MAP1S phosphorylation is lost in CDKL5 KO mouse brains and human CDD patient‐derived neurons.

    • MAP1S phosphorylation by CDKL5 directly impairs its microtubule binding and stabilizing properties.

    • CDKL5 regulates dendritic microtubule dynamics in a MAP1S‐dependent manner, resulting in altered cargo trafficking.

    • CDKL5
    • chemical genetics
    • EB2
    • MAP1S
    • microtubule dynamics

    The EMBO Journal (2018) e99763

    • Received May 3, 2018.
    • Revision received August 7, 2018.
    • Accepted August 31, 2018.
    • © 2018 The Francis Crick Institute. Published under the terms of the CC BY 4.0 license

    This is an open access article under the terms of the Creative Commons Attribution 4.0 License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.

    Lucas L Baltussen, Priscilla D Negraes, Margaux Silvestre, Suzanne Claxton, Max Moeskops, Evangelos Christodoulou, Helen R Flynn, Ambrosius P Snijders, Alysson R Muotri, Sila K Ultanir
    Published online 28.09.2018
    • Cell Adhesion, Polarity & Cytoskeleton
    • Genetics, Gene Therapy & Genetic Disease
    • Post-translational Modifications, Proteolysis & Proteomics
  • Open Access
    Resource
    Phosphoproteomic screening identifies physiological substrates of the CDKL5 kinase
    Phosphoproteomic screening identifies physiological substrates of the CDKL5 kinase
    1. Ivan M Muñoz1,†,
    2. Michael E Morgan1,†,
    3. Julien Peltier1,2,
    4. Florian Weiland1,
    5. Mateusz Gregorczyk1,
    6. Fiona CM Brown1,
    7. Thomas Macartney1,
    8. Rachel Toth1,
    9. Matthias Trost (matthias.trost{at}ncl.ac.uk)*,1,2 and
    10. John Rouse (j.rouse{at}dundee.ac.uk)*,1
    1. 1MRC Protein Phosphorylation and Ubiquitylation Unit, School of Life Sciences, University of Dundee, Dundee, UK
    2. 2Faculty of Medical Sciences, Institute for Cell and Molecular Biosciences, Newcastle upon Tyne, UK
    1. ↵* Corresponding author. Tel: +44 191 2087009; E‐mail: matthias.trost{at}ncl.ac.uk
      Corresponding author. Tel: +44 1382 385490; E‐mail: j.rouse{at}dundee.ac.uk
    1. ↵† These authors contributed equally to this work

    Identification of phosphorylation targets reveals a sequence preference for the neurodevelopmental disease‐linked CDKL5, and that pathogenic mutations decrease activity towards microtubule‐ and centrosome‐associated substrates.

    Synopsis

    CDKL5 kinase is mutated in a neurodevelopmental disease termed CDKL5 disorder but the cellular targets and functions of CDKL5 are unclear. A phosphoproteomic screen to identify cellular targets of CDKL5 now addresses this gap.

    • CDKL5 phosphorylates MAP1S, CEP131, and DLG5, proteins involved in regulation of microtubules and centrosomes.

    • In all three substrates, the phosphorylated serine lies in an RPXSA motif, with in vitro analysis showing certain amino acids other than Ala also tolerated C‐terminal to the phosphoacceptor serine.

    • CDKL5 activity is controlled by tyrosine auto‐phosphorylation in its T‐loop.

    • Pathogenic CDKL5 mutations cause severe reduction in kinase activity towards MAP1S and CEP131 in cells and in vitro.

    • CDKL5 disorder
    • centrosome
    • cilia
    • kinase
    • microtubule

    The EMBO Journal (2018) e99559

    • Received April 5, 2018.
    • Revision received August 14, 2018.
    • Accepted September 10, 2018.
    • © 2018 The Authors. Published under the terms of the CC BY 4.0 license

    This is an open access article under the terms of the Creative Commons Attribution 4.0 License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.

    Ivan M Muñoz, Michael E Morgan, Julien Peltier, Florian Weiland, Mateusz Gregorczyk, Fiona CM Brown, Thomas Macartney, Rachel Toth, Matthias Trost, John Rouse
    Published online 28.09.2018
    • Cell Adhesion, Polarity & Cytoskeleton
    • Genetics, Gene Therapy & Genetic Disease
    • Post-translational Modifications, Proteolysis & Proteomics
  • You have accessRestricted access
    News & Views
    ATF4‐amino acid circuits: a recipe for resistance in melanoma
    ATF4‐amino acid circuits: a recipe for resistance in melanoma
    1. Mario R Fernandez1 and
    2. John L Cleveland (john.cleveland{at}moffitt.org)1
    1. 1Department of Tumor Biology, H Lee Moffitt Cancer Center & Research Institute, Tampa, FL, USA

    Lactate dehydrogenase A (LDHA) has appropriately received attention as a therapeutic target for the treatment of a broad spectrum of tumor types, yet little is known regarding intrinsic resistance to LDHA inhibitors. Pathria et al (2018) now establish that ATF4‐dependent control of enzymes that direct amino acid metabolism confers resistance to LDHA inhibitors in melanoma and identify chokepoints that can be exploited to overcome metabolic compensation, setting the stage for trials with such combinations.

    See also: G Pathria et al

    A new study shows that ATF4‐mediated rewiring of amino acid metabolism mediates resistance to lactate dehydrogenase A inhibitors.

    The EMBO Journal (2018) e100600

    • © 2018 The Authors
    Mario R Fernandez, John L Cleveland
    Published online 28.09.2018
    • Cancer
    • Metabolism
All recent articles
Back to top


SmartFigures

Meet the Editors

Editor conference calendar

Subject areas

  • Ageing (28)
  • Cancer (206)
  • Cell Adhesion, Polarity & Cytoskeleton (487)
  • Cell Cycle (575)
  • Autophagy & Cell Death (474)
  • Chemical Biology (6)
  • Chromatin, Epigenetics, Genomics & Functional Genomics (1139)
  • Development & Differentiation (622)
  • DNA Replication, Repair & Recombination (864)
  • Genetics, Gene Therapy & Genetic Disease (9)
  • Immunology (561)
  • Membrane & Intracellular Transport (1133)
  • Metabolism (394)
  • Methods & Resources (59)
  • Microbiology, Virology & Host Pathogen Interaction (659)
  • Molecular Biology of Disease (694)
  • Neuroscience (730)
  • Physiology (22)
  • Plant Biology (264)
  • Post-translational Modifications, Proteolysis & Proteomics (870)
  • Protein Biosynthesis & Quality Control (177)
  • RNA Biology (748)
  • Signal Transduction (1267)
  • Stem Cells (248)
  • Structural Biology (888)
  • Systems & Computational Biology (88)
  • Transcription (172)
  • Vascular Biology & Angiogenesis (31)
Advertisement

Journal

  • Latest Online
  • Current Issue
  • Archive
  • Bibliometrics
  • E-Mail Editorial Office
  • Privacy Policy

Authors & Referees

  • Aims & Scope
  • Editors & Board
  • Transparent Process
  • Author Guidelines
  • Referee Guidelines
  • Open Access
  • Submit

Info

  • Alerts
  • RSS Feeds
  • Subscriptions & Access
  • Reprints & Permissions
  • Advertise & Sponsor
  • News & Press
  • Recommend to Librarian
  • Customer Service

EMBO

  • Funding & Awards
  • Events
  • Science Policy
  • Members
  • About EMBO

Online ISSN  1460-2075

Copyright© 2018 EMBO

This website is best viewed using the latest versions of all modern web browsers. Older browsers may not display correctly.